Deadlines this Week


Deadlines this Week


If you’re interested in issues involving the disclosure of risks and hazards related to medical care and surgical procedures, you may want to apply to be a member of the Texas Medical Disclosure Panel. The Texas Health and Human Services Commission executive commissioner will appoint a physician and an attorney licensed to practice in Texas to the panel to serve a term expiring Aug. 31, 2028.
Applications are due by 11:59 p.m., May 27.
HHSC will consider applicants' qualifications, background and interest in serving on the panel and will try to choose panel members who represent the diversity of all Texans. For this reason, HHSC considers applicants' ethnicity, gender and geographic location.
A Texas Medical Disclosure Panel member must regularly participate in panel meetings. They may also have to take part in subpanel meetings, projects and presentations. Panel meetings are held about once every three months in Austin or at the call of the presiding officer. To the extent permitted by the current state budget, a panel member may be repaid for their travel expenses to and from meetings if money is available and in accordance with the HHSC Travel Policy.

|
The first-ever National Fentanyl Awareness Day launches Tuesday, May 10, 2022. Download Social Media Assets #NationalFentanylAwarenessDay #FentanylAwareness Download Flyers for your OfficeVisit the National Fentanyl Awareness Day website for more information.You can find additional social media, draft emails to share with partners, key messages, and more using the official toolkit. Founded by parents who have lost loved ones to the drug overdose epidemic, National Fentanyl Awareness Day is supported by a group of subject matter experts, corporations, nonprofits, schools, families, and elected officials who are coming together to amplify the issue via social media. |
|
|
|
|
|

ACTION: Final rule.
SUMMARY: This rulemaking amends the Drug Enforcement Administration's (DEA) regulations to now require all applications for DEA registrations, and renewal of those registrations, to be submitted online.
DATES: This final rule is effective May 11, 2022.
FOR FURTHER INFORMATION CONTACT:
Scott A. Brinks, Regulatory Drafting and Policy Support Section, Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 776–2265.
|
Program Year 2021 data submission is open now through March 31, 2022. For details about registration, recertification and data submission, visit the Resources for Reporting Entities page.
TMB is requesting your participation in a very brief customer service survey. Every two years, all state agencies including the Texas Medical Board, are required to conduct a survey about various agency operations. We want to obtain your feedback to help us understand your impression of the TMB’s usage of video conferencing platforms and TMB in general.
The survey consists of 10 multiple choice questions, will take just a few minutes to complete, and is completely anonymous. The survey is available on Survey Monkey via this link: TMB Customer Service Survey.
We respectfully request your participation in the survey by Friday, April 29th, 2022. Your feedback is very important to us and the results of the survey will be published on the agency website as part of the 2022 Strategic Planning process.
FBI Liaison Information Report about Criminals Extorting Medical Professionals by Impersonating Medical Licensing Boards and the FBI. Click link below.
|
Physician applicants outside of Texas, and Texas physicians wishing to practice in another member state, can begin submitting applications to the Interstate Medical Licensure Compact Commission (IMLCC) on Tuesday, March 1. The Interstate Medical Licensure Compact is a voluntary, expedited pathway to licensure for qualifying physicians who wish to practice in Compact member states. For details on qualifying for Compact licensure, and Frequently Asked Questions, please visit: https://www.tmb.state.tx.us/page/interstate-medical-licensure-compact |
Did you know that TPS has it's very own Career Center?
If you're looking to fill a position, you need to look into this great resource that expands to various medical fields all across the US!
In addition to this resource, we want to help you get the word out. Let us know what positions you're looking for by filling out the form through the link below.
Below is a recap of the release announced on Forbes. Find the Proposed 2022 CDC Clinical Practice Guideline for Prescribing Opioids here. TPS will submit a formal response on behalf of TPS Members.
The Centers for Disease Control proposed pulling back some of the strict guidelines for prescribing opioids in a draft of recommendations released Thursday, a move that would loosen some of the restrictions put in place in 2016 to help mitigate the opioid epidemic, in an attempt to allow chronic pain patients to receive more flexible treatment.
Proposed changes to the CDC’s guidance include giving doctors more leeway by slashing dose ceilings for patients and no longer suggesting they limit opioid treatment for acute pain to three days. Doctors would be advised to only prescribe opioids for painful, traumatic injuries, like major burns and those sustained in car accidents, and start patients off on low doses of immediate-release pills, according to the New York Times.
To ease less intense conditions—like episodic migraines and knee, neck and lower back pain—the new recommendations suggest employing treatments like exercise, acupuncture, heat therapy and over-the-counter drugs like ibuprofen.
|
|
DWC reminds health care practitioners that they must file a financial interest disclosure with DWC when referring an injured employee to another health care practitioner, health care provider, or health care facility that they have a financial interest in.
More details are on the TDI website.Do you want to advance your status and exposure? You can with the American Board of Pain Management as a director! You have experiences, opinions, scientific facts that can drive the industry forward. Consider joining by contacting Dr. Finn below.
Ken Finn, MD